Drummond releases Q2 2026 FHIRplace testing report

Drummond Group released its FHIRplace Q2 2026 Testing Report on Aug. 25, highlighting structured FHIR testing for Coverage Requirements Discovery in prior authorization workflows. The report shows an 89% success rate across executed scenarios and underscores how multi-party testing can surface interoperability issues before deployment.

Why it matters: - Coverage Requirements Discovery is a key prior authorization workflow that lets payers and providers exchange coverage information before clinical decisions. - Drummond’s report shows structured, multi-party FHIR testing can surface interoperability issues early, before systems go live. - The 89% success rate on executed test scenarios points to both progress and remaining remediation work for health IT teams, payers, providers and intermediaries.

What happened: - Drummond Group released the FHIRplace Q2 2026 Testing Report on Aug. 25, 2026. - Q2 testing focused on Coverage Requirements Discovery, or CRD. - The testing covered coverage data exchange workflows across multiple participants. - The Q2 2026 report is available as the full testing report.

The details: - Drummond said FHIRplace participants executed structured FHIR testing across coverage data exchange workflows. - The program identified interoperability issues for remediation during testing. - The executed test scenarios produced an 89% success rate. - Drummond introduced an Issue Typology Metrics framework and reporting methodology to classify, track and resolve interoperability problems. - The framework is designed to show what was tested, what failed and how remediation progressed. - FHIRplace recognizes two levels of participation. - The FHIRplace Participant emblem marks organizations actively engaged in structured FHIR testing. - The Drummond Validated seal goes to organizations that demonstrate interoperability across the multi-party testing matrix. - Q2 2026 CRD testing participants included Medplum, Affosoft Inc., MEDITECH Expanse, Firely PAROD, HealthUnity Smart Authorization Gateway, Smile CDR Inc., PA Checkpoint, Medgen EMR and Medgen FHIR.

Between the lines: - Drummond is framing interoperability testing as a pre-deployment proving ground, not just a certification exercise. - The Issue Typology Metrics framework suggests the company wants to make testing outcomes more comparable and easier to act on across participants. - The Validated seal appears intended to signal a higher level of confidence than participation alone. - Timothy Bennett, director of strategic healthcare initiatives at Drummond Group, said organizations that complete FHIRplace testing and earn the seal prove their systems work in real-world multi-party conditions before go-live.

What's next: - Organizations interested in FHIRplace can receive structured test plans and test against a multi-party testing matrix. - Drummond said that approach helps participants identify and resolve interoperability issues faster. - More organizations may use the program to reduce integration friction and speed market readiness before deployment.

The bottom line: - Drummond is positioning FHIRplace as a practical interoperability checkpoint for health IT vendors and care-delivery stakeholders trying to prove systems work before launch. - More information is available at Drummond Group.